Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
LSZ
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
Pregabalin
4-AcO-MiPT
Bufotenin
ETH-LAD
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Enhancement of colour rose.jpgRose by Chelsea Morgan
5-MeO-DiBF
Experience:4-AcO-DMT + 200mg Pill
Psilocin
DPT
TMA-2
MPT
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
5F-PB-22
Aniracetam
Paradise island by Xanny.jpgParadise island by Subsentience
ALD-52
3C-E
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
5-Hydroxytryptophan
Βk-2C-B
1P-ETH-LAD
4-AcO-MET
Selective serotonin reuptake inhibitor
MDMA
Experience:250mg DXM - DXM Itch and Trip Report
4-AcO-DMT
Experience:300µg LSD - Togetherness and the Silent Dusk
2C-B-FLY
AL-LAD
Experience:800 seeds LSA - My First Trip Ever
Psilocybin mushrooms
25N-NBOMe
Coluracetam
Chameleon.jpgChameleon by Anonymous.
25B-NBOH
2C-T-21
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
25B-NBOMe
EPT
PARGY-LAD
2C-C
25I-NBOH
Experience:4x 200ug tabs - You do not need to understand
Experience:337mg DMT fumarate - A Day With DMT
2C-I
MDA
MDAI
DOB
GABAergic hallucinogens
Ayahuasca
Experience:1000 Morning Glory seeds - Rediscovering the Self
THJ-2201
5-MeO-DALT
Pramiracetam
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
3-MMC
DET
DiPT
4-HO-DiPT
2C-D
Experience:2 tabs DOB - My DOB Nightmare
Experience:1mg 25c-NBOMe - Experiment in my room
Experience:4.5g - The Grand Introduction to Beauty and Fear
Experience:3g mimosa / 3g syrian rue - Connecting with my body
PRO-LAD
Ibogaine
ΑMT
Amanita muscaria
MiPLA
Methallylescaline
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
MDEA
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
4-HO-DPT
4-HO-EPT
4-HO-MET
5-MeO-DiPT
Allylescaline
Oxiracetam
Efavirenz
Piracetam
Bromo-DragonFLY
LSD
25D-NBOMe
2C-T-7
Experience:~150mg MDA(oral) - a case of mistaken identity
4-HO-MPT
JWH-073
2C-B
Chur City in Switzerland.jpgChur, Switzerland by Naps284
LSM-775
LSA
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
Experience:300µg AL-LAD - Don't worry, because you're everyone!
4-AcO-DiPT
6-APDB
Experience:3-MeO-PCP - Extreme psychosis
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Proscaline
25C-NBOMe
Experience:40mg - Brothermind and the Forest's Hand
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
Experience:BK-2C-B - Various experiences
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
DMT
Tree.jpgJapanese Garden by Anonymous
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Escaline
MiPT
25C-NBOH
MET
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
DOI
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Memantine
6-APB
4-FA
4-HO-DET
4-HO-MiPT
4-AcO-DET
5-MeO-MiPT
DOM
1B-LSD
Experience:1050 µg 1cP-LSD - The matrix
2C-E
Experience:120mg - Garden of The Gods
Omberacetam
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
Phenethylamine (compound)
Mescaline
2C-T-2
Experience:25mg 3-MeO-PCP - Enhanced film experience
DOC
Phenylpiracetam
JWH-018
3-MeO-PCE
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
THJ-018
1P-LSD
2C-P
TMA-6
Experience:4-HO-MiPT / A care free psychedelic getaway
25I-NBOMe
2C-H

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.